Trials / Conditions / Renal Angiomyolipoma
Renal Angiomyolipoma
5 registered clinical trials studyying Renal Angiomyolipoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Ivonescimab in the Treatment of Multiple Advanced Tumors NCT06683846 | Fudan University | Phase 2 |
| Active Not Recruiting | Evaluation of a Simple-Prep Controlled Embolic NCT06453642 | Fluidx Medical Technology, Inc. | N/A |
| Active Not Recruiting | A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Wh NCT05252585 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tu NCT03525834 | Novartis Pharmaceuticals | Phase 4 |
| Terminated | Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) NCT02654340 | CENTOGENE GmbH Rostock | — |